Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research
WIN 55,212-2 - an overview | ScienceDirect Topics
WIN-55212-2 mesylate Supplier | CAS 131543-23-2 | Focus Biomolecules
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
Francesca Telese on LinkedIn: Our latest work on the role of cannabinoids in inflammation: The…
The structure of synthetic cannabinoid agonists WIN 55,212-2 (WIN).... | Download Scientific Diagram
Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain | Molecular Psychiatry
What is a cannabinoid? — Why Not THC
4 Dose-dependent induction of cannabinoid tetrad effects by the SCB WIN... | Download Scientific Diagram
Win 55212-2 | C27H26N2O3 | CID 5311501 - PubChem
Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells - ScienceDirect
The cannabinoid agonist WIN 55,212-2 (WIN) reversibly inhibits... | Download Scientific Diagram
Effect of the synthetic cannabinoid agonist WIN 55212-2 (WIN) on... | Download Scientific Diagram
The cannabinoid receptor agonist WIN 55,212-2 (WIN) (( R)... | Download Scientific Diagram
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain - ScienceDirect
WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris Bioscience
Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity - Mouro - 2018 - Journal of Neurochemistry - Wiley Online Library
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells | Prostate Cancer and Prostatic Diseases
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &
Gestational exposure to the cannabinoid WIN 55,212-2 and its effect on the innate intestinal immune response | Scientific Reports
Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-d-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons | Journal of Pharmacology and Experimental Therapeutics
Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain | Journal of Pharmacology and Experimental Therapeutics
